Wire Stories

MOGU Inc. Announces Resignation of Chief Financial Officer

HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (“MOGU” or the “Company”), a leading online fashion and…

Indonesia 2020: Air Treatment Systems Market Insights – Sales by Key Areas, Technology & End-user Trends, Distribution Market Share – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "2020 Air Treatment Systems Market: Indonesia" report has been added to ResearchAndMarkets.com's offering.…

Indian Metal Industry Outlook, FY 2019 – Set to Witness a 6% Y-o-Y Demand Growth in FY 2020 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indian Metal Industry Outlook, FY 2019" report has been added to ResearchAndMarkets.com's offering.…

RELX Receives Red Dot Award: Product Design 2020 for RELX Infinity

BEIJING--(BUSINESS WIRE)--RELX Technology, Asia’s leading e-cigarette brand, has been awarded the Red Dot Award: Product…

University of Nottingham Ningbo China Offers British Degrees With Affordability

NINGBO, China--(BUSINESS WIRE)--There are many questions a prospective student may ask about a university before…

Ubiquitome’s COVID-19 Fast Test Device in Spotlight

AUCKLAND, New Zealand--(BUSINESS WIRE)--Ubiquitome’s ability to deliver fast test results for COVID-19 is attracting global…

CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for CG0070 in Japan and Other Asian Countries

- Kissei Gains Regional License to CG0070 for Japan, South Korea, Taiwan and Other Asian…

Dr. Reddy’s Laboratories Issues Voluntary Nationwide Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (along with its subsidiaries together referred…

Autodoc donates EUR 50,000 for coronavirus research

Berlin-based company sets standards for commitment BERLIN--(BUSINESS WIRE)--Autodoc, Europe’s largest online retailer of car spare…

Poxel Reports Financial Results for Full Year 2019 and Provides Corporate Update

Successful completion of Imeglimin Phase 3 TIMES program in Japan for the treatment of type…